// App-Quantinova.ai

: WITHDRAWN: Postmenopausal Hormone Use and Venous Thromboembolism Risk in a Prospective Cohort Study: Exploring Effect Modification by Genetic Risk Factors

Researchers

Presenter

  • J. Kim

Principal Investigators

  • S.N. Bhupathiraju

  • L.B. Harrington

  • K.A. Hagan

  • S. Lindstrom

  • J.E. Manson

  • P. Kraft

  • C. Kabrhel

Medical Centers

  • Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, United States

  • Brigham and Women's Hospital and Harvard Medical School, Channing Division of Network Medicine, Boston, MA

  • Kaiser Permanente Washington Health Research Institute, Seattle, United States

  • Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, United States

  • University of Washington, Department of Medicine, Seattle, WA

  • Brigham and Women's Hospital / Harvard Medical School, Hematology Division, Department of Medicine, Boston, United States

  • Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, United States

  • Massachusetts General Hospital, Department of Surgery, Boston, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved